Welcome!

News Feed Item

ZELTIQ Announces First Quarter 2014 Financial Results

Increases Full Year 2014 Revenue Guidance

PLEASANTON, CA -- (Marketwired) -- 04/29/14 -- ZELTIQ® (NASDAQ: ZLTQ)

  • Total revenue of $31.0 million, up 55% compared to $20.0 million in Q1 2013
  • 179 systems shipped, compared to 112 systems in Q1 2013, bringing total system installed base to 2,354 systems
  • 142,317 cycles shipped, up 83% from Q1 2013

ZELTIQ®, (NASDAQ: ZLTQ) a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced financial results for the first quarter 2014.

Mark Foley, President and Chief Executive Officer, said, "After a transformative 2013, our organization continued to execute and maintain the momentum generated last year by further building on key strategic initiatives which we believe will drive our long term success. We further differentiated our innovative technology, partnered with physician practices to drive utilization, leveraged our platform to treat more areas of the body, and achieved deeper penetration of the large and growing non-invasive body contouring market. We saw strong year-over-year increases in our consumable utilization rate which we believe is a direct result of the various initiatives and programs beginning to gain traction through our Practice Development Managers, and our Area Sales Managers drove another strong quarter of system placements while still increasing the already robust pipeline of system leads in our queue. Our strong progress on many of our key initiatives and execution by our sales force led to outstanding 55% year-over-year revenue growth in the first quarter and the further strengthening of CoolSculpting's established market leadership position."

Mr. Foley continued, "We also achieved two major milestones that we believe are significant to our long term growth strategy. In March, we launched our revolutionary non-suction based, surface applicator, CoolSmooth, designed to treat expanded areas of the body without the need to draw tissue away from the body. CoolSmooth saw strong pre-order demand during the quarter and we began shipping the product in early April. It is a platform on which we intend to further build, leveraging our unique technology. In April, we received FDA clearance across our entire applicator portfolio for the treatment of thighs. These two developments further strengthen our ability to drive deeper market penetration, and we expect a corresponding increase in demand for system sales over the course of 2014. Accordingly, we made significant investments in the first quarter in both sales and marketing and in inventory for both CoolSculpting systems and CoolSmooth applicators. We have included in today's release as well as on our website some additional key metrics which we believe will provide greater transparency in the health and future growth of our business. We remain excited about the potential in 2014 and our confidence has led us to increase our full year 2014 revenue guidance to $137 million to $140 million."

First Quarter Financial Review
Total net revenue for the first quarter 2014 was $31.0 million, consisting of $14.5 million of system revenue and $16.5 million of consumable revenue. This compares to total net revenue of $20.0 million, consisting of $11.1 million of system revenue and $8.9 million of consumable revenue for the first quarter 2013. Total cycles shipped increased 83% to 142,317 for the first quarter 2014, compared to 77,559 for the first quarter 2013.

Gross profit was $22.0 million, or 71% of revenue, for the first quarter 2014, compared to gross profit of $12.6 million, or 63% of revenue, for the first quarter 2013. Operating expenses for the first quarter 2014 were $29.2 million, compared to $20.1 million for the first quarter 2013.

Loss from operations for the first quarter 2014 was $7.2 million, compared to $7.5 million for the first quarter 2013. Net loss for the first quarter 2014 was $7.3 million, or $0.20 per share, compared to $7.5 million for the first quarter 2013, or $0.21 per share. Weighted average basic and diluted shares outstanding for the first quarter 2014 and first quarter 2013 was 37.2 million and 35.9 million, respectively.

Cash and cash equivalents, short-term investments, and long-term investments were $41.2 million as of March 31, 2014 compared to $51.6 million as of March 31, 2013, and $56.1 million as of December 31, 2013.

Revised Full Year 2014 Financial Guidance
ZELTIQ is updating its previously stated financial guidance for the full year 2014, provided on its fourth quarter and full year 2013 earnings conference call:

  • Revenue guidance in the range of $137 million to $140 million; up from prior guidance of $134 to $137 million
  • Consumable revenue of approximately 50% of total revenue; unchanged from prior guidance
  • Gross profit of approximately 70%; unchanged from prior guidance
  • Operating expenses of approximately 80% of total revenue; unchanged from prior guidance
  • Adjusted EBITDA margin of approximately (3%); new metric from prior guidance

Additional information regarding our results and guidance can be found in our Supplemental Financial and Operational Information schedule by CLICKING HERE or by visiting the Investor Relations section of our website at www.zeltiq.com.

Use of Non-GAAP Financial Measures
ZELTIQ has supplemented its GAAP net loss with a non-GAAP measure of Adjusted EBITDA. Management believes that this non-GAAP financial measure provides useful supplemental information to management and investors regarding the performance of ZELTIQ, facilitates a more meaningful comparison of results for current periods with previous operating results, and assists management in analyzing future trends, making strategic and business decisions and establishing internal budgets and forecasts. A reconciliation of non-GAAP Adjusted EBITDA to GAAP net loss in the most directly comparable GAAP measure is provided in the schedule below.

There are limitations in using this non-GAAP financial measure because it is not prepared in accordance with GAAP and may be different from non-GAAP financial measures used by other companies. This non-GAAP financial measure should not be considered in isolation or as a substitute for GAAP financial measures. Investors and potential investors should consider non-GAAP financial measures only in conjunction with the ZELTIQ's consolidated financial statements prepared in accordance with GAAP and the reconciliations of the non-GAAP financial measure provided in the schedule below.

Conference Call
ZELTIQ will hold a conference call on Tuesday, April 29, 2014 at 4:30 p.m. ET to discuss the results. The dial-in numbers are (877) 280-7291 for domestic callers and (707) 287-9361 for international callers. A live webcast of the conference call will be available online from the investor relations page of ZELTIQ's corporate website at www.coolsculpting.com.

After the live webcast, the call will remain available on ZELTIQ's website, www.coolsculpting.com, until ZELTIQ releases its second quarter 2014 financial results. In addition, a telephonic replay of the call will be available until May 6, 2014. The replay dial-in numbers are (855) 859-2056 for domestic callers and (404) 537-3406 for international callers. Please use the replay conference ID number 29315879.

About ZELTIQ® Aesthetics
ZELTIQ is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting System, is designed to selectively reduce stubborn fat bulges. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer.

Forward-Looking Statements
The statements made in this press release regarding ZELTIQ's belief that continued building on key strategic initiatives will drive its long term success, its expectation of an increase in demand for system sales over the course of 2014, its belief regarding the potential for 2014 and its financial guidance for 2014 are forward-looking statements. The words "believe," "expect," "potential" and "guidance" and similar words that denote future events or results identify these forward-looking statements. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond ZELTIQ's control and that could materially affect ZELTIQ's actual business operations and financial performance and condition. Factors that could materially affect ZELTIQ's business operations and financial performance and condition include, but are not limited to: less than anticipated growth in the number of physicians electing to purchase CoolSculpting Systems; patient demand for CoolSculpting procedures may be lower than ZELTIQ expects; product or procedure announcements by competitors may decrease demand for CoolSculpting procedures; ZELTIQ may incorrectly estimate or control its future expenditures; ZELTIQ's sales and marketing plans may fail to increase sales as ZELTIQ expects; as well as those other risks and uncertainties set forth in ZELTIQ's Current Report on Form 10-K for the fiscal year ended December 31, 2013, filed with the SEC on February 26, 2014. These forward-looking statements speak only as of the date of this press release. ZELTIQ expressly disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events or otherwise.

                           ZELTIQ Aesthetics, Inc.
                         Consolidated Balance Sheets
                               (In Thousands)
                                 (Unaudited)

                                                   March 31,   December 31,
                                                      2014          2013
                                                 ------------- -------------
ASSETS
CURRENT ASSETS:
  Cash and cash equivalents                      $      14,546 $      25,798
  Short-term investments                                18,442        18,840
  Accounts receivable, net                              12,318        10,221
  Inventory                                             15,231         8,406
  Prepaid expenses and other current assets              3,676         4,368
                                                 ------------- -------------
    Total current assets                                64,213        67,633
  Long-term investments                                  8,234        11,442
  Restricted cash                                          332           331
  Property and equipment, net                            2,340         2,158
  Intangible asset, net                                  6,306         6,481
  Other assets                                             103             9
                                                 ------------- -------------
    Total assets                                 $      81,528 $      88,054
                                                 ============= =============

LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
  Accounts payable                               $       6,195 $       5,165
  Accrued liabilities                                   17,127        18,364
  Deferred revenue                                       2,532         1,674
                                                 ------------- -------------
    Total current liabilities                           25,854        25,203
Other non-current liabilities                              204           275
                                                 ------------- -------------
    Total liabilities                            $      26,058 $      25,478
                                                 ------------- -------------
STOCKHOLDERS' EQUITY:
    Total stockholders' equity                          55,470        62,576
                                                 ------------- -------------
    Total liabilities and stockholders' equity   $      81,528 $      88,054
                                                 ============= =============



                          ZELTIQ Aesthetics, Inc.
                    Consolidated Statement of Operations
                               (In Thousands)
                                (Unaudited)

                                                    Three Months Ended
                                                 March 31,      March 31,
                                                    2014           2013
                                               -------------  -------------
Revenue                                        $      30,975  $      19,982
Cost of revenue                                        9,016          7,348
                                               -------------  -------------
  Gross profit                                        21,959         12,634
                                               -------------  -------------
Operating expenses:
  Research and development                             4,270          3,749
  Sales and marketing                                 20,187         12,542
  General and administrative                           4,713          3,808
                                               -------------  -------------
    Total operating expenses                          29,170         20,099
                                               -------------  -------------
Loss from operations                                  (7,211)        (7,465)
Interest income, net                                      19             24
Other expense, net                                       (66)           (34)
                                               -------------  -------------
Loss before provision for income taxes                (7,258)        (7,475)
Provision for income taxes                                79              7
                                               -------------  -------------
Net loss                                              (7,337)        (7,482)
                                               =============  =============
Net loss per share, basic and diluted          $       (0.20) $       (0.21)
                                               =============  =============
Weighted average shares of common stock
 outstanding used in computing net loss per
 share, basic and diluted                         37,215,697     35,890,084
                                               =============  =============


                          ZELTIQ Aesthetics, Inc.
                    Consolidated Statement of Cash Flows
                               (In Thousands)
                                (Unaudited)
                                                      Three Months Ended
                                                           March 31,
                                                       2014         2013
                                                   -----------  -----------
CASH FLOWS FROM OPERATING ACTIVITIES:
  Net loss                                         $    (7,337) $    (7,482)
  Adjustments to reconcile net loss to net cash
   used in operating activities:
    Depreciation and amortization                          455          428
    Stock-based compensation                             2,105        1,119
    Deferred income tax provision (benefit)                 30          (20)
    Amortization (accretion) of investment premium
     (discount), net                                        67           94
    Provision for doubtful accounts receivable               -           25
    Provision for excess and obsolete inventory            105           82
    Loss on disposal and write-off of property and
     equipment                                              17            2
    Changes in operating assets and liabilities:
     Accounts receivable                                (2,088)       1,100
     Inventory                                          (6,291)       1,284
     Prepaid expenses and other assets                     570         (776)
     Deferred revenue, net of deferred costs               853         (359)
     Accounts payable, accrued and other non-
      current liabilities                                 (829)      (2,506)
                                                   -----------  -----------
     Net cash used in operating activities             (12,343)      (7,009)
                                                   -----------  -----------
CASH FLOWS FROM INVESTING ACTIVITIES:
  Purchase of investments                               (2,249)      (7,319)
  Sale of investments                                    1,000        3,750
  Proceeds from maturity of investments                  4,791        4,448
  Purchase of property and equipment                      (559)         (68)
  Change in restricted cash                                 (1)         107
                                                   -----------  -----------
     Net cash provided by investing activities           2,982          918
                                                   -----------  -----------
CASH FLOWS FROM FINANCING ACTIVITIES:
  Proceeds from issuance of common stock upon
   exercise of stock options                               640           68
  Tax payments related to shares withheld for
   vested restricted stock units                        (2,546)          (7)
                                                   -----------  -----------
     Net cash (used in) provided by financing
      activities                                        (1,906)          61
                                                   -----------  -----------
Effect of exchange rate on cash and cash
 equivalents                                                15            -
                                                   -----------  -----------
NET INCREASE (DECREASE) IN CASH AND CASH
 EQUIVALENTS                                           (11,252)      (6,030)
CASH AND CASH EQUIVALENTS-Beginning of period           25,798       22,876
                                                   -----------  -----------
CASH AND CASH EQUIVALENTS-End of period            $    14,546  $    16,846
                                                   ===========  ===========



                          ZELTIQ Aesthetics, Inc.
  Reconciliation of Net Loss to Adjusted Earnings Before Interest, Taxes,
                                Depreciation,
        Amortization and Stock-Based Compensation (Adjusted EBITDA)
                               (In Thousands)
                                (Unaudited)

                                                      Three Months Ended
                                                    March 31,    March 31,
                                                       2014         2013
                                                   -----------  -----------
Net loss, as reported                              $    (7,337) $    (7,482)

Adjustments to net loss:
  Interest income and other expense, net                    47           10
  Provision for income taxes                                79            7
  Depreciation and amortization                            455          428
  Stock-based compensation expense                       2,105        1,119
                                                   -----------  -----------
    Total adjustments to net loss                        2,686        1,564

Adjusted EBITDA                                    $    (4,651) $    (5,918)
                                                   ===========  ===========
Adjusted EBITDA as a percentage of revenue                 -15%         -30%
                                                   ===========  ===========


More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
Containers and Kubernetes allow for code portability across on-premise VMs, bare metal, or multiple cloud provider environments. Yet, despite this portability promise, developers may include configuration and application definitions that constrain or even eliminate application portability. In this session we'll describe best practices for "configuration as code" in a Kubernetes environment. We will demonstrate how a properly constructed containerized app can be deployed to both Amazon and Azure ...
We are seeing a major migration of enterprises applications to the cloud. As cloud and business use of real time applications accelerate, legacy networks are no longer able to architecturally support cloud adoption and deliver the performance and security required by highly distributed enterprises. These outdated solutions have become more costly and complicated to implement, install, manage, and maintain.SD-WAN offers unlimited capabilities for accessing the benefits of the cloud and Internet. ...
Business professionals no longer wonder if they'll migrate to the cloud; it's now a matter of when. The cloud environment has proved to be a major force in transitioning to an agile business model that enables quick decisions and fast implementation that solidify customer relationships. And when the cloud is combined with the power of cognitive computing, it drives innovation and transformation that achieves astounding competitive advantage.
DXWorldEXPO LLC announced today that "IoT Now" was named media sponsor of CloudEXPO | DXWorldEXPO 2018 New York, which will take place on November 11-13, 2018 in New York City, NY. IoT Now explores the evolving opportunities and challenges facing CSPs, and it passes on some lessons learned from those who have taken the first steps in next-gen IoT services.
SYS-CON Events announced today that Silicon India has been named “Media Sponsor” of SYS-CON's 21st International Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Published in Silicon Valley, Silicon India magazine is the premiere platform for CIOs to discuss their innovative enterprise solutions and allows IT vendors to learn about new solutions that can help grow their business.
In his general session at 19th Cloud Expo, Manish Dixit, VP of Product and Engineering at Dice, discussed how Dice leverages data insights and tools to help both tech professionals and recruiters better understand how skills relate to each other and which skills are in high demand using interactive visualizations and salary indicator tools to maximize earning potential. Manish Dixit is VP of Product and Engineering at Dice. As the leader of the Product, Engineering and Data Sciences team at D...
In this presentation, you will learn first hand what works and what doesn't while architecting and deploying OpenStack. Some of the topics will include:- best practices for creating repeatable deployments of OpenStack- multi-site considerations- how to customize OpenStack to integrate with your existing systems and security best practices.
SYS-CON Events announced today that CrowdReviews.com has been named “Media Sponsor” of SYS-CON's 22nd International Cloud Expo, which will take place on June 5–7, 2018, at the Javits Center in New York City, NY. CrowdReviews.com is a transparent online platform for determining which products and services are the best based on the opinion of the crowd. The crowd consists of Internet users that have experienced products and services first-hand and have an interest in letting other potential buye...
In his session at 20th Cloud Expo, Scott Davis, CTO of Embotics, discussed how automation can provide the dynamic management required to cost-effectively deliver microservices and container solutions at scale. He also discussed how flexible automation is the key to effectively bridging and seamlessly coordinating both IT and developer needs for component orchestration across disparate clouds – an increasingly important requirement at today’s multi-cloud enterprise.
Security, data privacy, reliability and regulatory compliance are critical factors when evaluating whether to move business applications from in-house client hosted environments to a cloud platform. In her session at 18th Cloud Expo, Vandana Viswanathan, Associate Director at Cognizant, In this session, will provide an orientation to the five stages required to implement a cloud hosted solution validation strategy.
You want to start your DevOps journey but where do you begin? Do you say DevOps loudly 5 times while looking in the mirror and it suddenly appears? Do you hire someone? Do you upskill your existing team? Here are some tips to help support your DevOps transformation. Conor Delanbanque has been involved with building & scaling teams in the DevOps space globally. He is the Head of DevOps Practice at MThree Consulting, a global technology consultancy. Conor founded the Future of DevOps Thought Leade...
Jo Peterson is VP of Cloud Services for Clarify360, a boutique sourcing and benchmarking consultancy focused on transforming technology into business advantage. Clarify360 provides custom, end-to-end solutions from a portfolio of more than 170 suppliers globally. As an engineer, Jo sources net new technology footprints, and is an expert at optimizing and benchmarking existing environments focusing on Cloud Enablement and Optimization. She and her team work with clients on Cloud Discovery, Cloud ...
Everyone wants the rainbow - reduced IT costs, scalability, continuity, flexibility, manageability, and innovation. But in order to get to that collaboration rainbow, you need the cloud! In this presentation, we'll cover three areas: First - the rainbow of benefits from cloud collaboration. There are many different reasons why more and more companies and institutions are moving to the cloud. Benefits include: cost savings (reducing on-prem infrastructure, reducing data center foot print, redu...
Founded in 2000, Chetu Inc. is a global provider of customized software development solutions and IT staff augmentation services for software technology providers. By providing clients with unparalleled niche technology expertise and industry experience, Chetu has become the premiere long-term, back-end software development partner for start-ups, SMBs, and Fortune 500 companies. Chetu is headquartered in Plantation, Florida, with thirteen offices throughout the U.S. and abroad.
The technologies behind big data and cloud computing are converging quickly, offering businesses new capabilities for fast, easy, wide-ranging access to data. However, to capitalize on the cost-efficiencies and time-to-value opportunities of analytics in the cloud, big data and cloud technologies must be integrated and managed properly. Pythian's Director of Big Data and Data Science, Danil Zburivsky will explore: The main technology components and best practices being deployed to take advantage...